Company Overview of Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc., a clinical stage diabetes therapeutics company, designs and develops insulin-based therapies for the treatment of diabetes in the United States. The company’s products include Oral HVD-I, a targeted oral insulin in a pill or gel cap dose form; HDV-I, an injectable short acting insulin; and HDV-B, an injectable basal long acting insulin. It develops products for patients suffering from Type 1 and Type 2 diabetes. Diasome Pharmaceuticals, Inc. was founded in 2004 and is based in Cleveland, Ohio.
10000 Cedar Avenue
Cleveland, OH 44106
Founded in 2004
Key Executives for Diasome Pharmaceuticals, Inc.
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Diasome Pharmaceuticals, Inc., please visit www.diasome.com. Company data is provided by Capital IQ. Please use this form to report any data issues.